F
Feng Chen
Researcher at Northwestern University
Publications - 31
Citations - 4023
Feng Chen is an academic researcher from Northwestern University. The author has contributed to research in topics: Apoptosis & Caspase. The author has an hindex of 25, co-authored 30 publications receiving 3742 citations.
Papers
More filters
Journal ArticleDOI
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
T. Chris Gamblin,Feng Chen,Angara Zambrano,Aida Abraha,Sarita Lagalwar,Angela L. Guillozet,Meiling Lu,Yifan Fu,Francisco García-Sierra,Nichole E. LaPointe,Richard J. Miller,Robert W. Berry,Lester I. Binder,Vincent L. Cryns +13 more
TL;DR: A novel mechanism linking amyloid deposition and neurofibrillary tangles in AD is suggested: Aβ peptides promote pathological tau filament assembly in neurons by triggering caspase cleavage of tau and generating a proteolytic product with enhanced polymerization kinetics.
Journal ArticleDOI
Catechol Polymers for pH-Responsive, Targeted Drug Delivery to Cancer Cells
TL;DR: This study demonstrated that the cancer-targeting drug–polymer conjugates dramatically enhanced cellular uptake, proteasome inhibition, and cytotoxicity toward breast carcinoma cells in comparison with nontargeting drug-polymer Conjugates.
Journal ArticleDOI
The Small Heat Shock Protein αB-Crystallin Negatively Regulates Cytochrome c- and Caspase-8-dependent Activation of Caspase-3 by Inhibiting Its Autoproteolytic Maturation
TL;DR: It is demonstrated that αB-crystallin is a novel negative regulator of apoptosis that acts distally in the conserved cell death machinery by inhibiting the autocatalytic maturation of caspase-3.
Journal ArticleDOI
Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.
TL;DR: It is suggested that caspase proteolysis of vimentin promotes apoptosis by dismantling intermediate filaments and by amplifying the cell death signal via a pro-apoptotic cleavage product.
Journal ArticleDOI
αB-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer
Jose V. Moyano,Joseph R. Evans,Feng Chen,Meiling Lu,Michael E. Werner,Fruma Yehiely,Leslie K. Diaz,Dmitry Turbin,Gamze Karaca,Elizabeth L. Wiley,Torsten O. Nielsen,Charles M. Perou,Vincent L. Cryns +12 more
TL;DR: The results indicate that alphaB-crystallin is a novel oncoprotein expressed in basal-like breast carcinomas that independently predicts shorter survival and implicate the MEK/ERK pathway as a potential therapeutic target for these tumors.